Creo Medical Group PLC financials at a glance

+ Portfolio

The revenue of Creo Medical Group PLC is reported as 0.02717 billion Pounds in the fiscal year 2023. The earnings were -0.15 Pounds per share in 2023, which was 0 higher than 2021. And about -0.02521 billion Pounds are reported as free cash flow in the financials of Creo Medical Group PLC 2023. No dividends were paid to the shareholders of the Creo Medical Group PLC stock AIM:CREO in the financial year 2023.

£27.17M

Revenue

£-0.15

Earnings Per Share

48.30%

Gross Margin %

£-28.16M

Free Cash Flow

Revenue

27.17

Earnings Per Share

-0.15

Gross Margin %

48.30

Free Cash Flow

-28.16

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016
Rev.	Revenue	N/A	£27.17M	£25.16M	£9.43M	£0.01M	£0.00M	£0.00M	£0.00M
GM %	Gross Margin %	48.25%	48.30%	46.04%	42.79%	36.75%	0.00%	0.00%	0.00%
OM	Operating Margin	-96.20%	-,113.20%	-,118.86%	-,245.48%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	£-0.11	£-0.15	£-0.15	£-0.13	£-0.13	£-0.16	£-0.11	£-2.10
Div.	Dividends	N/A	£0.00	£0.00	£0.00	£0.00	£0.00	£0.00	£0.00
PR %	Payout Ratio %	0	0	-0.00%	0	0	0	0	0
Sha.	Shares	N/AM	181.38M	178.1M	157.89M	150.38M	120.5M	80.71M	33.21M
OCF	Operating Cash Flow	N/A	£-24.98M	£-26.01M	£-16.28M	£-11.85M	£-14.30M	£-6.91M	£0.00M
FCF	Free Cash Flow	N/A	£-28.16M	£-31.84M	£-16.76M	£-12.33M	£-15.02M	£0.00M	£0.00M
FCFS	Free Cash Flow Per Share	£-0.11	£-0.16	£-0.20	£-0.11	£-0.11	£-0.12	£0.00	£0.00

Creo Medical Group PLC financials at a glance

Financials

Discover